ORMP - Oramed Pharmaceuticals Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5143.6M
Enterprise Value 3117.39M
Trailing P/E -11.37
Forward P/E 1-8.62
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)65.54
Price/Book (mrq)7.25
Enterprise Value/Revenue 353.58
Enterprise Value/EBITDA 6-10.25

Financial Highlights

Fiscal Year
Fiscal Year Ends Aug 31, 2016
Most Recent Quarter (mrq)May 31, 2017
Profitability
Profit Margin 0.00%
Operating Margin (ttm)-522.91%
Management Effectiveness
Return on Assets (ttm)-18.82%
Return on Equity (ttm)-49.39%
Income Statement
Revenue (ttm)2.19M
Revenue Per Share (ttm)0.17
Quarterly Revenue Growth (yoy)278.50%
Gross Profit (ttm)151k
EBITDA -11.45M
Net Income Avi to Common (ttm)-12.54M
Diluted EPS (ttm)-0.95
Quarterly Earnings Growth (yoy)N/A
Balance Sheet
Total Cash (mrq)26.2M
Total Cash Per Share (mrq)1.97
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)5.23
Book Value Per Share (mrq)1.49
Cash Flow Statement
Operating Cash Flow (ttm)3.02M
Levered Free Cash Flow (ttm)-2.45M

Trading Information

Stock Price History
Beta 0.72
52-Week Change 356.18%
S&P500 52-Week Change 319.09%
52 Week High 311.34
52 Week Low 35.70
50-Day Moving Average 310.06
200-Day Moving Average 38.38
Share Statistics
Avg Vol (3 month) 366.23k
Avg Vol (10 day) 334.49k
Shares Outstanding 513.32M
Float 9.7M
% Held by Insiders 128.76%
% Held by Institutions 110.24%
Shares Short 3185.14k
Short Ratio 35.93
Short % of Float 31.98%
Shares Short (prior month) 3208.31k
Dividends & Splits
Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/12
Last Split Date 3Jan 23, 2013